Table 2.
Recurrent cancer patient diagnosis
| AA (n=5) | AG (n=8) | GG (n=1) | p value | |
|---|---|---|---|---|
| Treatment* | ||||
| CTx. | 1 (14.3) | 5 (71.4) | 1 (14.3) | 0.192 |
| RTx. | 4 (33.3) | 7 (58.3) | 1 (8.3) | 0.852 |
| HTx. | 4 (33.3) | 7 (58.3) | 1 (8.3) | 0.852 |
| Type of recurrence | 0.297 | |||
| Local recurrence | 4 (80.0) | 2 (25.0) | 1 (100) | |
| Regional recurrence | 0 | 1 (12.5) | 0 | |
| Distant recurrence | 1 (20.0) | 5 (62.5) | 0 | |
| Pathologic results† | 0.607 | |||
| DCIS | 2 (40.0) | 2 (25.0) | 0 | |
| IBC | 2 (40.0) | 2 (25.0) | 1 (100) | |
| Other breast cancer | 1 (20.0) | 1 (12.5) | 0 | |
| Distant metastasis | 0 | 3 (37.5) | 0 |
Values are number of patients (%).
* Treatments were performed after breast cancer surgery. †Pathologic results were confirmed by surgical biopsy after recurrent breast cancer was detected. DCIS: ductal carcinoma in situ; IBC: invasive breast cancer; CTx.: chemotherapy; RTx.: radiation therapy; HTx.: hormonal therapy.